These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15335019)
41. Antioxidant properties of soybean isoflavone extract and tofu in vitro and in vivo. Liu J; Chang SK; Wiesenborn D J Agric Food Chem; 2005 Mar; 53(6):2333-40. PubMed ID: 15769177 [TBL] [Abstract][Full Text] [Related]
42. [Effects of antiatherosclerosis diet including soy protein on the dynamics of clinical, biochemical and immunologic indicators in patients with ischemic heart disease and hypertension]. Pogozheva AV; Kondakova MN; Pokrovskaia GR; Mal'tsev GIu Vopr Pitan; 1999; 68(4):27-31. PubMed ID: 10509453 [TBL] [Abstract][Full Text] [Related]
43. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy]. Reĭzin AB; Tel'nykh IuV Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943 [TBL] [Abstract][Full Text] [Related]
44. [Pathophysiological aspects of endotoxicosis complicated with purulent infection of the foot and correction of endotoxicosis with conventional treatment and with application of ozonized physiological solution in patients suffering from diabetes mellitus]. Gazin IK Patol Fiziol Eksp Ter; 2008; (4):23-5. PubMed ID: 19198268 [TBL] [Abstract][Full Text] [Related]
45. A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulation. Ravn-Haren G; Bügel S; Krath BN; Hoac T; Stagsted J; Jørgensen K; Bresson JR; Larsen EH; Dragsted LO Br J Nutr; 2008 Apr; 99(4):883-92. PubMed ID: 17888202 [TBL] [Abstract][Full Text] [Related]
46. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed? Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061 [TBL] [Abstract][Full Text] [Related]
47. Influence of therapy on the antioxidant status in patients with melanoma. Gadjeva V; Dimov A; Georgieva N J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784 [TBL] [Abstract][Full Text] [Related]
48. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy--induced hypertension. Krishna Mohan S; Venkataramana G Indian J Physiol Pharmacol; 2007; 51(3):284-8. PubMed ID: 18341226 [TBL] [Abstract][Full Text] [Related]
49. [Effects of extracorporeal hemo-correction on lipid peroxidation in patients in critical states]. Chalenko VV; Zhilkina SV; Pastukhova NK; Kutushev FKh; Romanchishen AF Vestn Khir Im I I Grek; 2001; 160(3):55-9. PubMed ID: 11517792 [TBL] [Abstract][Full Text] [Related]
50. [The clinical significance of selenium deficiency in patients from the Samara region with cardiovascular diseases and its correction with the preparation Selena]. Kuznetsov GP; Lebedev PA Eksp Klin Farmakol; 1995; 58(5):26-8. PubMed ID: 8704583 [TBL] [Abstract][Full Text] [Related]
51. [Antioxidants in the combined treatment of acute cholecystitis in middle-aged and elderly patients]. Feofilov GL; Vorob'ev IV; Semeniuk AV; Motsartov VD; Kulikova LA Vestn Khir Im I I Grek; 1992 Jan; 148(1):16-21. PubMed ID: 1338825 [TBL] [Abstract][Full Text] [Related]
52. [The study of the clinical potency of antiatherogenic diet containing flavonoids in cardiovascular patients]. Lysikova SL; Pogozheva AV; Akol'zina SE; Vasil'ev AV; Vorob'eva LSh Vopr Pitan; 2003; 72(3):8-11. PubMed ID: 12872654 [TBL] [Abstract][Full Text] [Related]
53. [Selenium and cardiovascular pathology]. Neve J Pathol Biol (Paris); 1989 Dec; 37(10):1102-6. PubMed ID: 2691967 [TBL] [Abstract][Full Text] [Related]
54. Glucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficial. Ajdžanović VZ; Milošević VLj; Spasojević IB Gen Physiol Biophys; 2012 Dec; 31(4):367-74. PubMed ID: 23255662 [TBL] [Abstract][Full Text] [Related]
55. [Effect of a biologically active supplement (BAD) "SeleniumES" on the antioxidant system in patients with cardiovascular diseases]. Vasil'ev AV; Shimanovskaia NP; Khachaturova VP; Mal'tsev GIu Biomed Khim; 2003; 49(3):291-6. PubMed ID: 14564740 [TBL] [Abstract][Full Text] [Related]
56. [Free radicals and related substances in cardiovascular diseases]. Feigl D; Mikunis R Harefuah; 1996 May; 130(10):702-5. PubMed ID: 8794664 [No Abstract] [Full Text] [Related]
57. [Effects of antioxidant therapy on the energy metabolism system and antioxidant defense during the acute period of myocardial infarction]. Sokolov IM Anesteziol Reanimatol; 1995; (5):21-3. PubMed ID: 8533956 [TBL] [Abstract][Full Text] [Related]
58. [Various indices of lipid metabolism in patients with gastroduodenal pathology]. Mazhul' LM; Dalidovich KK; Gul'ko VV; Shablinskaia OV; Volykhina VE; Gatsko GG Vopr Med Khim; 1990; 36(4):10-1. PubMed ID: 2238520 [TBL] [Abstract][Full Text] [Related]
59. Soybeans or soymilk: does it make a difference for cardiovascular protection? Does it even matter? Steinberg FM Am J Clin Nutr; 2007 Apr; 85(4):927-8. PubMed ID: 17413087 [No Abstract] [Full Text] [Related]
60. [Effect of antioxidants on lipid metabolism and fibrogenesis disorders in lung tissue in experimental silicosis]. Babushkina LG; Katsnel'son BA; Kisklitsina NS Vopr Med Khim; 1981; 27(4):466-9. PubMed ID: 7293078 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]